Healthcare Wrap Week 7: Pro Medicus and Cochlear slide as Noxopharm surges on Nature Immunology

• Pro Medicus (ASX:PME) fell 🔴 -25.00% even after reporting record half-year results and $280m+ in new contracts
• Noxopharm (ASX:NOX) rose 🟢 27.12% after Sofra™ research landed in Nature Immunology
• Cochlear (ASX:COH) slid 🔴 -20.37% as profit fell and the Nexa implant rollout took longer than planned
• CSL (ASX:CSL) dropped 🔴 -16.89% after a large reported profit fall tied to restructuring and impairments